TYK Medicines
CompanyChinaFounded 2017
TYK Medicines develops one asset, in phase 1 (TY-302 in breast cancer). Mostly small molecule; based in China, founded in 2017.
- 1
- Asset
- Furthest stage
- Phase 1
- 2
- Trials
- 0
- Signals
Pipeline
1Antineoplastic agent
Phase 1, Small molecule, breast cancer, solid tumor
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials2
- Similar companies6